News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
218,992 Results
Type
Article (4958)
Company Profile (20)
Press Release (214014)
Section
Business (82031)
Career Advice (458)
Deals (15036)
Drug Delivery (8)
Drug Development (19022)
Employer Resources (30)
FDA (3665)
Job Trends (3891)
News (119824)
Policy (7496)
Tag
Academia (290)
Africa (181)
Alabama (12)
Alliances (14658)
Alzheimer's disease (199)
Approvals (3655)
Arizona (40)
Asia (11196)
Australia (1518)
Bankruptcy (93)
Best Places to Work (2780)
Biotechnology (18)
C2C Services and Suppliers (25402)
California (476)
Canada (293)
Cancer (72)
Career advice (389)
Cell therapy (22)
China (14)
Clinical research (15372)
Collaboration (19)
Colorado (13)
Compensation (13)
Connecticut (19)
COVID-19 (282)
Cystic fibrosis (10)
Data (45)
Diagnostics (1943)
Diversity, equity & inclusion (12)
Earnings (39321)
Employer resources (29)
Europe (23615)
Events (36326)
Executive appointments (40)
FDA (3696)
Florida (59)
Funding (17)
GLP-1 (86)
Government (403)
Healthcare (4974)
Hotbed/Location (163147)
Idaho (23)
Illinois (56)
Indiana (27)
Infectious disease (284)
Inflammatory bowel disease (19)
Interviews (53)
IPO (7698)
Job creations (1116)
Job search strategy (360)
Kansas (23)
Layoffs (94)
Legal (2319)
Liver cancer (14)
Lung cancer (11)
Maine (31)
Maryland (71)
Massachusetts (456)
Medical device (3778)
Medtech (3779)
Mergers & acquisitions (7297)
Metabolic disorders (28)
Michigan (44)
Minnesota (82)
Montana (16)
Nebraska (12)
Neuroscience (212)
New Hampshire (13)
New Jersey (174)
New York (184)
NextGen Class of 2024 (1669)
Non-profit (721)
North Carolina (201)
Northern California (245)
Obesity (20)
Ohio (23)
Opinion (26)
Pennsylvania (126)
People (23917)
Phase I (4557)
Phase II (6679)
Phase III (5320)
Pipeline (64)
Postmarket research (625)
Preclinical (1793)
Press Release (66)
Rare diseases (19)
Real estate (1866)
Regulatory (4906)
Reports (13)
Research institute (296)
Resumes & cover letters (68)
South America (273)
Southern California (186)
Startups (1005)
Texas (52)
United States (2296)
Utah (14)
Vaccines (15)
Washington State (49)
Date
Last 7 days (137)
Last 30 days (776)
Last 365 days (11810)
2024 (7840)
2023 (13191)
2022 (18658)
2021 (19679)
2020 (18239)
2019 (13205)
2018 (10205)
2017 (10002)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
218,992 Results for "vystar corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Vystar Adds Vytex into RxAir Spin-off, Sets Spin-Off Record Date, Opens Opportunity for Reverse Merger Into Vystar/Rotmans
Vystar® Corporation announces that it plans to split into two companies via a dividend. In addition to the previously announced spin-off of RxAir® air purification and Fluid Energy Conversion subsidiaries into a separate, publicly traded company, Vystar plans to add a third subsidiary, Vytex® latex and rubber, into the spin-off.
February 23, 2022
·
7 min read
Business
Vystar appoints Dr. Byron Novosad to Board of Directors
Vystar® Corporation (OTCQB: VYST) has named Byron Novosad, DDS, to the Vystar Board of Directors, effective immediately.
February 23, 2021
·
4 min read
Biotech Beach
Vystar Partners with “Nothing in the Air” for RxAir Marketing, Advertising & Distribution
Vystar® Corporation’s RxAir® division has joined forces with a powerful new ally, Nothing in the Air, to market and distribute the RxAir ultraviolet light air purifier product line.
June 2, 2021
·
6 min read
Business
Vystar Posts Highest Revenue & Profit in Company History in First Quarter 2021
Vystar® Corporation reports milestone financial results for the first quarter of 2021 with record high revenue and profit for the first time in the company’s history.
May 24, 2021
·
7 min read
Deals
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.
May 28, 2024
·
9 min read
Genetown
Vystar Issues Corporate Update on Strategic Initiatives and the Impact of COVID-19 on Brands
Vystar Corporation, parent company of RxAir® UV light air purification products, Rotmans Furniture and Floor Covering, and Vytex® deproteinized rubber and latex, has managed numerous initiatives though the challenges of the COVID-19 pandemic and has emerged with a new and stronger supply chain, reliable manufacturing partners, an improved product offering and a growing market presence and distribution network.
February 1, 2021
·
10 min read
Pharm Country
Quest Diagnostics Releases 2023 Corporate Responsibility Report
Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.
June 27, 2024
·
3 min read
Biotech Bay
Aridis Provides Corporate Update - June 24, 2024
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
June 24, 2024
·
8 min read
Business
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.
May 13, 2024
·
15 min read
Genetown
Bruker Corporation to Present at Upcoming June 2024 Investor Conferences
Bruker Corporation announced it will present at the following conferences.
May 31, 2024
·
2 min read
1 of 21,900
Next